SomaLogic Revenue and Competitors

Location

$956.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • SomaLogic's estimated annual revenue is currently $127.4M per year.(i)
  • SomaLogic's estimated revenue per employee is $217,000
  • SomaLogic's total funding is $956.5M.

Employee Data

  • SomaLogic has 587 Employees.(i)
  • SomaLogic grew their employee count by -11% last year.

SomaLogic's People

NameTitleEmail/Phone
1
Product OwnerReveal Email/Phone
2
Interim CEOReveal Email/Phone
3
Product OwnerReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
Chief Science OfficerReveal Email/Phone
6
Chief Medical OfficerReveal Email/Phone
7
CTOReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Interim Chief Financial OfficerReveal Email/Phone
10
SVP, Innovation & New Market DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$664.9M915-14%$20.8M$178.6M
Add Company

What Is SomaLogic?

Revolutionizing Proteomics To Transform Healthcare SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Building on the previous decade of aptamer research, SomaLogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences. Our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare. If you would like to learn more about SomaLogic, contact us at information@somalogic.com or 303-625-9000

keywords:N/A

$956.5M

Total Funding

587

Number of Employees

$127.4M

Revenue (est)

-11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

SomaLogic News

2022-04-20 - Brokerages Anticipate SomaLogic, Inc. (NASDAQ:SLGC) to ...

Two analysts have provided estimates for SomaLogic's earnings, with the lowest EPS estimate coming in at ($0.17) and the highest estimate coming...

2022-04-06 - SomaLogic Inc: A Biopharmaceutical Company With An Excellent Upside

SomaLogic offers a pioneering platform for the study and engineering of various proteins, which lends itself to a large number of diseases...

2022-03-22 - SomaLogic Reports Fourth Quarter and Full Year 2021 ...

SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide...

2021-08-31 - SomaLogic expands leadership team with new positions to drive commercial success

NEW YORK and BOULDER, Colo., Aug. 31, 2021 (GLOBE NEWSWIRE) -- CM Life Sciences II (NASDAQ: CMIIU) and SomaLogic, a leader in AI data-driven proteomics technology, today announced the recent appointments of Todd Johnson as Executive Vice President of Business Development and Strategy and Ruben G ...

2021-03-29 - SomaLogic To Go Public Via SPAC

SomaLogic, a Boulder, CO-based global leader in proteomics technology, and CM Life Sciences II (NASDAQ: CMIIU), a special purpose acquisition company, sponsored by affiliates of Casdin Capital, LLC and Corvex Management LP, entered into a definitive business combination deal. Upon closing of th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$150.4M587-6%N/A
#2
$198.1M5875%N/A
#3
$198.1M5879%N/A
#4
$185.6M5875%N/A
#5
$3.5M5872%N/A